sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Transmucosal Drug Delivery Systems Market Scope And Analysis

  • Report Code : TIPRE00004209
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Transmucosal Drug Delivery Systems Market - Analysis 2031

Buy Now

Transmucosal Drug Delivery Systems Market Report Transmucosal Drug Delivery Systems Market Size and Share Transmucosal Drug Delivery Systems Market Scope and Analysis

Transmucosal Drug Delivery Systems Market Report Scope

Report Attribute Details
Market size in 2023 US$ 80.21 Billion
Market Size by 2031 US$ 129.46 Billion
Global CAGR (2023 - 2031) 6.2%
Historical Data 2021-2023
Forecast period 2023-2031
Segments Covered By System
  • Nasopulmonary
  • Buccal & Sublingual
  • Vaginal
By End User
  • Healthcare facilities
  • Homecare Settings
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Teva Pharmaceutical Industries Ltd
  • Cigna Corporation
  • BioDelivery Sciences International Inc
  • 3M
  • Henkel Finland Oy
  • GlaxoSmithKline plc
  • Aquestive Therapeutics Inc
  • Camurus AB
  • Ximedica